v3.26.1
Unaudited Condensed Consolidated Interim Statements of Changes in Stockholders’ Deficit - USD ($)
$ in Thousands
Previously Reported
Common Stock
Previously Reported
Additional paid-in capital
Previously Reported
Accumulated deficit
Previously Reported
Accumulated Other Comprehensive Income (Loss)
Previously Reported
Non- controlling interest
Preferred Stock
Common Stock
Additional paid-in capital
Accumulated deficit
Accumulated Other Comprehensive Income (Loss)
Non- controlling interest
Total
Balance (in Shares) at Sep. 30, 2023             1,259,333          
Balance at Sep. 30, 2023               $ 25,544 $ (31,769) $ 32   $ (6,193)
Stock-based compensation               230       230
Issuance of Old Nukk common stock in exchange for a receivable from Brilliant               1,802       1,802
Issuance of Old Nukk common stock in exchange for a receivable from Brilliant (in Shares)             47,533          
Issuance of Old Nukk common stock to settle accrued expenses and other current liabilities               213       213
Issuance of Old Nukk common stock to settle accrued expenses and other current liabilities (in Shares)             5,629          
Issuance of common stock to settle accrued expenses and other current liabilities               1,880       1,880
Issuance of common stock to settle accrued expenses and other current liabilities (in Shares)             361,532          
Issuance of stock purchase warrants               518       518
Issuance of common stock to settle loans payable – related parties               271       271
Issuance of common stock to settle loans payable – related parties (in Shares)             8,767          
Issuance of common stock to settle due to affiliates               2,727       2,727
Issuance of common stock to settle due to affiliates (in Shares)             94,710          
Issuance of common stock in connection with reverse recapitalization               150       150
Issuance of common stock in connection with reverse recapitalization (in Shares)             321,495          
Foreign currency translation adjustments                   (177)   (177)
Comprehensive income (loss) for the period                 (8,519)     (8,519)
Balance (in Shares) at Sep. 30, 2024 2,098,999           2,098,999          
Balance at Sep. 30, 2024               33,335 (40,288) (145)   (7,098)
Rounding of post-split shares outstanding per transfer agent (in Shares) 57                      
Stock-based compensation               6       6
Issuance of common stock as compensation for services               1,364       1,364
Issuance of common stock as compensation for services (in Shares) 847,500                      
Issuance of common stock in connection with Exit and Settlement Agreement               325       325
Issuance of common stock in connection with Exit and Settlement Agreement (in Shares) 140,100                      
Issuance of common stock as compensation to board of directors               959       959
Issuance of common stock as compensation to board of directors (in Shares) 690,000                      
Issuance of common stock to settle accrued expenses and other current liabilities               760       760
Issuance of common stock to settle accrued expenses and other current liabilities (in Shares) 354,660                      
Issuance of common stock, net of issuance of costs               478       478
Issuance of common stock, net of issuance of costs (in Shares) 249,263                      
Issuance of common stock to settle convertible notes payable               771       771
Issuance of common stock to settle convertible notes payable (in Shares) 319,952                      
Issuance of common stock in connection with private placement and embedded derivative, net of issuance costs (in Shares) 230,000                      
Reclassification of stock purchase warrants from equity-classified to liability-classified               (238)       (238)
Foreign currency translation adjustments                   111   111
Comprehensive income (loss) for the period                 (160,788)     (160,788)
Balance (in Shares) at Dec. 31, 2024 4,930,531         0 39,444 [1]          
Balance at Dec. 31, 2024   $ 37,760 $ (201,076) $ (34)   $ 0 [2] 37,760 (201,076) (34) $ 0 (163,350)
Issuance of common stock from exercise of pre-funded warrants (in Shares) [1]             667          
Issuance of common stock from exercise of pre-funded warrants             [2] 3,056       3,056
Stock-based compensation               178       178
Foreign currency translation adjustments                   (59)   (59)
Comprehensive income (loss) for the period                 102,958     102,958
Balance (in Shares) at Mar. 31, 2025           0 40,111 [1]          
Balance at Mar. 31, 2025           $ 0 $ 0 [2] 40,994 (98,118) (93) 0 (57,217)
Balance (in Shares) at Dec. 31, 2024 4,930,531         0 39,444 [1]          
Balance at Dec. 31, 2024   37,760 (201,076) (34)   $ 0 [2] 37,760 (201,076) (34) 0 (163,350)
Comprehensive income (loss) for the period                       105,977
Balance (in Shares) at Jun. 30, 2025           0 42,967 [1]          
Balance at Jun. 30, 2025           $ 0 $ 0 [2] 41,932 (95,099) (216) 0 (53,383)
Balance (in Shares) at Dec. 31, 2024 4,930,531         0 39,444 [1]          
Balance at Dec. 31, 2024   37,760 (201,076) (34)   $ 0 [2] 37,760 (201,076) (34) 0 (163,350)
Issuance of common stock in relation to settlement agreement   157                   157
Issuance of common stock in relation to settlement agreement (in Shares) 12,500                      
Issuance of common stock from exercise of options (in Shares) 85,710                      
Issuance of common stock from exercise of warrants (in Shares) 7,185,861                      
Issuance of common stock from exercise of warrants $ 1 31,918                   31,919
Issuance of common stock in relation to conversion of note   1,792                   1,792
Issuance of common stock in relation to conversion of note (in Shares) 503,455                      
Issuance of common stock in exchange for digital assets   4,360                   4,360
Issuance of common stock in exchange for digital assets (in Shares) 522,710                      
Issuance of equity-classified warrants   7,080                   7,080
Adjustments in relation to deconsolidation of subsidiary       213               213
Commitment to issue shares as penalty   300                   300
Shares issued as commitment for ELOC agreement   1,250                   1,250
Issuance of shares as collateral for investment (in Shares) 2,000,000                      
Stock-based compensation (in Shares) 3,370,000                      
Stock-based compensation $ 1 18,825                   18,826
Issuance of common stock and warrants for services performed   2,817                   2,817
Issuance of common stock and warrants for services performed (in Shares) 310,000                      
Issuance of shares for settlement of debt on related party (in Shares) 105,000                      
Issuance of shares for settlement of debt on related party   509                   509
Capital contribution – SCII   882     $ 6,108             6,990
Accretion of noncontrolling interests subject to possible redemption   (4,913)     (1,981)             (6,894)
Foreign currency translation adjustments       $ (179)               (179)
Comprehensive income (loss) for the period     78,549   82             78,631
Balance (in Shares) at Dec. 31, 2025 19,025,767         0 152,206 [1]          
Balance at Dec. 31, 2025 $ 2 102,737 (122,527)   4,209 $ 0 $ 2 102,737 (122,527) 0 4,209 (15,579)
Balance (in Shares) at Mar. 31, 2025           0 40,111 [1]          
Balance at Mar. 31, 2025           $ 0 $ 0 [2] 40,994 (98,118) (93) 0 (57,217)
Issuance of common stock in relation to settlement agreement             $ 0 [2] 157       157
Issuance of common stock in relation to settlement agreement (in Shares) [1]             100          
Issuance of common stock from exercise of options [2]             $ 0 0        
Issuance of common stock from exercise of options (in Shares) [1]             674          
Issuance of common stock in relation to conversion of note             $ 0 [2] 781       781
Issuance of common stock in relation to conversion of note (in Shares) [1]             2,082          
Foreign currency translation adjustments                   (123)   (123)
Comprehensive income (loss) for the period                 3,019     3,019
Balance (in Shares) at Jun. 30, 2025           0 42,967 [1]          
Balance at Jun. 30, 2025           $ 0 $ 0 [2] 41,932 (95,099) (216) 0 (53,383)
Balance (in Shares) at Dec. 31, 2025 19,025,767         0 152,206 [1]          
Balance at Dec. 31, 2025 $ 2 102,737 (122,527)   4,209 $ 0 $ 2 102,737 (122,527) 0 4,209 (15,579)
Issuance of common stock from exercise of warrants (in Shares) [1]             27,871          
Issuance of common stock from exercise of warrants             $ 0 [2] 4,960 0     4,960
Stock-based compensation (in Shares) [1]             3,800          
Stock-based compensation             $ 0 [2] 1,907 0     1,907
Issuance of common stock in relation to private placement (in Shares) [1]             19,512          
Issuance of common stock in relation to private placement             $ 0 [2] 0 [2] 0     0 [2]
Issuance of preferred stock in relation to private placement (in Shares)           200 0 [1]          
Issuance of preferred stock in relation to private placement               0        
Issuance of common stock for purchase of subsidiaries (in Shares) [1]             52,963          
Issuance of common stock for purchase of subsidiaries             $ 1 24,902 0     24,903
Conversion of note into equity             $ 0 [2] 3,153 0     3,153
Conversion of note into equity (in Shares) [1]             13,000          
Equity classified warrants issued as part of purchase of subsidiaries               45,646 0     45,646
Shares issued as penalty (in Shares) [1]             585          
Shares issued as penalty             $ 0 [2] 0 0     0 [2]
Shares issued to settle commitment under ELOC agreement (in Shares) [1]             2,439          
Shares issued to settle commitment under ELOC agreement             $ 0 [2] 0 0     0 [2]
Issuance of shares from ELOC exercises (in Shares) [1]             31,745          
Issuance of shares from ELOC exercises             $ 1 3,529 0     3,530
Issuance of shares for settlement of debt on related party (in Shares) [1]             1,600          
Issuance of shares for settlement of debt on related party             $ 0 [2] 300 0     300
Subsidiary consolidation for the first time               0   (139) 1,739 1,600
Accretion of noncontrolling interests subject to possible redemption               (1,275) 0   (514) (1,789)
Foreign currency translation adjustments               0 0 115 128 243
Comprehensive income (loss) for the period               0 (27,147)   796 (26,351)
Balance (in Shares) at Mar. 31, 2026           200 305,721 [1]          
Balance at Mar. 31, 2026           $ 0 $ 4 185,859 (149,674) (24) 6,358 42,523
Balance (in Shares) at Dec. 31, 2025 19,025,767         0 152,206 [1]          
Balance at Dec. 31, 2025 $ 2 $ 102,737 $ (122,527)   $ 4,209 $ 0 $ 2 102,737 (122,527) 0 4,209 $ (15,579)
Shares issued to settle commitment under ELOC agreement (in Shares)                       14,800
Comprehensive income (loss) for the period                       $ (107,780)
Balance (in Shares) at Jun. 30, 2026           200 758,660 [1]          
Balance at Jun. 30, 2026           $ 0 $ 10 207,104 (232,162) (276) 5,665 (19,659)
Balance (in Shares) at Mar. 31, 2026           200 305,721 [1]          
Balance at Mar. 31, 2026           $ 0 $ 4 185,859 (149,674) (24) 6,358 42,523
Issuance of common stock from exercise of warrants (in Shares) [1]             211,544          
Issuance of common stock from exercise of warrants             $ 3 12,795       12,798
Issuance of common stock in connection with the VisionWave share exchange (in Shares) [1]             48,000          
Issuance of common stock in connection with the VisionWave share exchange             $ 1 2,353       2,354
Issuance of common stock in relation to conversion of note               2,139       2,139
Issuance of common stock in relation to conversion of note (in Shares) [1]             33,395          
Issuance of shares from ELOC exercises (in Shares) [1]             160,000          
Issuance of shares from ELOC exercises             $ 2 4,541       4,543
Transaction with non-controlling interests and deconsolidation of subsidiary               358     (1,140) (782)
Accretion of noncontrolling interests subject to possible redemption               (941)     (380) (1,321)
Foreign currency translation adjustments                   (252) (231) (483)
Comprehensive income (loss) for the period                 (82,488)   1,058 (81,430)
Balance (in Shares) at Jun. 30, 2026           200 758,660 [1]          
Balance at Jun. 30, 2026           $ 0 $ 10 $ 207,104 $ (232,162) $ (276) $ 5,665 $ (19,659)
[1] Share amounts have been retroactively adjusted to reflect the 1-for-125 Reverse Stock Split (see Note 1).
[2] Less than $1 thousand.